Dr Natalie Cook has been awarded a 5-year National Institute for Health and Care Research (NIHR) Rosetrees Trust Advanced Fellowship. The £730,000 award will fund an ambitious and exciting programme of research into cancer of unknown primary (CUP). https://www.christie.nhs.uk/research-and-innovation/research-newsroom/research-news/christie-consultant-awarded-5-year-advanced-clinical-fellowship
The abstract presented at ESMO by Dr Harpreet Wasan – PI of the CUP-One trial: A prospective double-blind validation of molecular classifiers in the diagnosis of Cancer of Unknown Primary and clinical outcome. CUP-ONE esmo abs
LBA16 – Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP) Background With platinum-based CTX, prognosis of patients (pts) with unfavourable CUP is poor; however, CGP may inform treatment strategies
Read more
Prof. Penelope Schofield, Talk Topic: Understanding Lived Experiences of People with CUP: How can clinicians help? 📅 Thursday 19th October 2023 ⏰ 08:00 – 09:00 🎟 To register please email
[email protected] 📍 MS Teams (link provided following registration).
The DRAFT NICE quality standard on suspected cancer update can be seen here for stakeholder comments by 18 Sep: https://www.nice.org.uk/guidance/indevelopment/gid-qs10176/consultation/html-content-7 The issue for CUP patients has always been around initial presentation (to GPs) with non site-specific symptoms and it is encouraging to see the espoused theory in the update: ‘If results of tests in primary care cannot establish the most
Read more
Will Quince MP, Minister for Health and Secondary Care, has taken over from Helen Whately. (He has already announced that he will be standing down at the next election.) As The Minister of State for Health and Secondary Care he is responsible for: NHS secondary care: o elective care recovery o hospital reconfigurations o special measures regime major diseases o
Read more
Yesterday the Specialised healthcare alliance (SHCA) launched a report entitled ‘Navigating the labyrinth: reducing delays to a rare disease diagnosis’. Whilst CUP is not, strictly speaking, a rare disease it is ‘less common’ and complex. This report makes useful recommendations for those with a Symptom Without a Name (SWAN)
The Secretary of State has just published his mandate for 2023 to NHS England. ‘ The priorities for improving cancer outcomes: Comment: Sunt facta verbis difficiliora
Confused about the Test Directory and how to get patients a genomic test? The Genomics Education Programme can tell you more
The NICE Surveillance Team have decided not to update the Guideline at the moment but to keep it under review. Their reasoning is shown here. They have however agreed one change which reflects the introduction of Whole Genome Sequencing in England in October 2022: Due to changes in practice, we will replace recommendation 1.2.2.9 that says not to use gene-expression-based
Read more